Molbio Diagnostics Limited (NSE:MOLBIO)
India · Delayed Price · Currency is INR 1,322.60
-112.20 (-7.82%)
Oct 21, 2026, 3:29 PM IST
Molbio Diagnostics Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Molbio Diagnostics stock has a consensus rating of "Strong Buy" and an average price target of ₹1,650. The average 1-year stock price forecast is 24.75% higher than the current stock price, while the lowest is ₹1,550 (+17.19%) and the highest is ₹1,800 (+36.10%).
Price Target: ₹1,650 (+24.75%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Molbio Diagnostics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Motilal Oswal No rating | Motilal Oswal | Buy Maintains ₹1,800 | Buy | Maintains | ₹1,800 | +36.10% | Oct 7, 2026 |
Financial Forecast
Revenue This Year
18.01B
from 14.46B
Increased by 24.58%
Revenue Next Year
22.57B
from 18.01B
Increased by 25.29%
EPS This Year
23.09
EPS Next Year
35.85
from 23.09
Increased by 55.28%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.